Caption Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-31,600
Closed -$76.8K 1335
2023
Q4
$94.5K Buy
+31,600
New +$41K ﹤0.01% 1181
2022
Q3
Sell
-12,300
Closed -$84.5K 1598
2022
Q2
$78K Buy
+12,300
New +$69.7K ﹤0.01% 1314
2021
Q3
Sell
-25,589
Closed -$373K 1591
2021
Q2
$542K Buy
25,589
+939
+4% +$22.6K 0.01% 1024
2021
Q1
$691K Buy
+24,650
New +$727K 0.01% 752
2020
Q4
Sell
-3,000
Closed -$111K 1060
2020
Q3
$111K Sell
3,000
-18,504
-86% -$733K ﹤0.01% 944
2020
Q2
$1.1M Buy
21,504
+7,804
+57% +$327K 0.04% 512
2020
Q1
$431K Buy
+13,700
New +$723K 0.02% 572
2019
Q4
Sell
-4,400
Closed -$198K 881
2019
Q3
$161K Buy
+4,400
New +$174K 0.01% 605
2019
Q1
Sell
-15,000
Closed -$690K 615
2018
Q4
$690K Buy
+15,000
New +$723K 0.06% 302

Other funds holding ESPR